Contract Development Services

Characterization and Qualification of Processes

February 26, 2025

Contract manufacturers have special expertise in the characterization and validation of biopharmaceutical manufacturing processes.

Supplying Sustainably

February 25, 2025

Sponsor companies and contract development and manufacturing companies must ensure that the suppliers they use are following sustainability guidelines to truly produce ‘green’ products.

Working Together to Improve the Environment

February 25, 2025

Contractors are working with sponsor companies to establish and maintain sustainable manufacturing practices in pharma.

Lonza to Provide Tailored Offering for the Development of Oral Biologics Using Smart Capsules

December 04, 2024

With its new offering, Lonza can tailor services to support smart capsule companies with its bi-layer capsule manufacturing technology.

Integrating Strategies for Formulation Success

August 11, 2024

Employing novel technologies and more patient-centric approaches can help to reduce the potential of formulation failure.

CordenPharma Leverages Peptide Drug Discovery and Development with GENEPEP and Works on Reducing Emissions

April 18, 2024

CordenPharma’s partnership with GENEPEP expedites lead development and validation in project phases, and its LNP β-sitosterol supports sustainable emission reduction targets.

Navigating the Preclinical CRO Outsourcing Process

February 16, 2024

The need for preclinical testing expertise is growing as molecular complexity increases.

Best Practice Tech Transfer Methods for CGTs

November 02, 2023

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.

TriLink BioTechnologies Launches Analytical Sciences Center of Excellence

November 02, 2023

The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.

eXmoor pharma Expands into Full-Service Cell and Gene Therapy CDMO Partner with Opening of GMP Facilities

October 12, 2023

The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.